PMA device
Paradigm Spine Coflex Interlaminar Stabilization Device
Companion Spine France · Prosthesis, Spinous Process Spacer/Plate (NQO, Class III) · First FDA decision Jun 21, 2018, newest Jun 21, 2018Degenerative disc disease and spinal stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
212
Naming "Paradigm"
MAUDE reports
375,737
Brand "Paradigm", since 2015
PubMed studies
186,591
Mentioning "Paradigm"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Paradigm Spine Coflex Interlaminar Stabilization Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Paradigm Spine Coflex Interlaminar Stabilization DevicePMA supplement
P110008-S009 · Decided Jun 21, 2018 · 353 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Paradigm", any status and sponsor, newest update first.
- Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal TinnitusPivotal-lookingRecruiting
University of Dublin, Trinity CollegeAcademic, hospital or other
NCT07393880 · 100 participants (planned) · Start Jun 30, 2026 · Primary completion Sep 30, 2028
Device: Real NITESGON; Sham NITESGON · For: Tinnitus, Subjective; Tinnitus; Chronic Tinnitus
Sites: Dublin, Ireland
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)Not yet recruiting
National Institute on Drug Abuse (NIDA)NIH
NCT06868914 · 40 participants (planned) · Start Nov 24, 2026 · Primary completion Jan 13, 2028
Device: TMS (MagVenture MagPro 100 with MagOption) · For: Healthy Volunteers
Sites: Hartford, Connecticut; Baltimore, Maryland
Zhengli DiAcademic, hospital or other
NCT07656129 · 30 participants · Start Jun 22, 2026 · Primary completion Aug 31, 2026
Device: external Trigeminal Nerve Stimulation, eTNS · For: Parkinson's Disease (PD)
Sites: Xi'an, China
209 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Paradigm", and for the whole product code for context.
This brand
375,737 reports: 294,674 malfunction, 79,708 injury, 1,310 death
Whole product code NQO
2,342 reports: 1,410 malfunction, 926 injury, 1 death
Newest reports for this brand
- MMT-712 PARADIGM Insulin PumpMalfunction
Medtronic Puerto Rico Operations Co.
2032227-2026-264268 · Received Oct 30, 2026 · Event dated Sep 29, 2026
Device type: Pump, Infusion, Insulin (LZG)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MMT-712 PARADIGM Insulin PumpMalfunction
Medtronic Puerto Rico Operations Co.
2032227-2026-264270 · Received Oct 30, 2026 · Event dated Sep 29, 2026
Device type: Pump, Infusion, Insulin (LZG)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-264782 · Received Oct 30, 2026 · Event dated Oct 9, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Mechanical Problem; Obstruction of Flow
Patient problem as coded: Hyperglycemia; Malaise
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Paradigm"[tiab]. The summary above synthesizes these.
- From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction.
McLaren J, de Alencar JN, Aslanger EK, et al. · JACC Adv · 2024Review
- Annual Research Review: Shifting from 'normal science' to neurodiversity in autism science.
Pellicano E, den Houting J · J Child Psychol Psychiatry · 2022Research Support, Non-U.S. Gov't, Review
- ASD-Time for a paradigm shift.
Levy Y · Front Psychiatry · 2022
- A paradigm shift in clinical nutrition.
Cardenas D, Ochoa JB · Clin Nutr · 2023
- The Uniqueness of the Humanbecoming Paradigm.
Bunkers SS, Kabigting ER · Nurs Sci Q · 2023
- The detour paradigm in animal cognition.
Kabadayi C, Bobrowicz K, Osvath M · Anim Cogn · 2018Research Support, Non-U.S. Gov't, Review
- A new paradigm for regulatory sciences.
Hilton GM, Bhuller Y, Doe JE, et al. · Regul Toxicol Pharmacol · 2023Review
- The Th1/Th2 paradigm: A misrepresentation of helper T cell plasticity.
Rogozynski NP, Dixon B · Immunol Lett · 2024Review, Research Support, Non-U.S. Gov't
- The neurosociological paradigm of the metaverse.
Maslova O, Shusharina N, Pyatin V · Front Psychol · 2024
- Paradigm Shift: Outcomes from a Physician-Scientist Undergraduate Pipeline Program.
Jones AC, McCaw TR, Seay RL, et al. · Res Sq · 2024Preprint
- When I say ߪ neurodiversity paradigm.
Shaw SCK, Brown MEL, Jain NR, et al. · Med Educ · 2025
- Recognizing electrocardiographically subtle occlusion myocardial infarction and differentiating it from mimics: Ten steps to or away from cath lab.
Aslanger EK, Meyers HP, Smith SW · Turk Kardiyol Dern Ars · 2021Review
Other devices of this type
Also filed under product code NQO.
- Superion Indirect Decompression SystemBoston Scientific Neuromodulation · PMA 2024
- coflex® Interlaminar TechnologyCompanion Spine France · PMA 2026
- X-Stop Interspinous Spacer SystemMedtronic Sofamor Danek, Inc. · PMA 2012
- Superion Interspinous SpacerBoston Scientific Neuromodulation · PMA 2017
- coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2021
- X Stop Interspinous Process Decompression SystemMedtronic Sofamor Danek, Inc. · PMA 2006
- DIAM Spinal Stabilization SystemCompanion Spine France Sas · PMA 2025
- X-Stop LtosMedtronic Sofamor Danek, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.